No Detail Found!

3-substituted coumarin derivatives over-activate the hslv protease: a potential drug target for antibacterial activity

Author(s)
Sana Aurangzeb Department of Biochemistry, University of Karachi,Karachi,Pakistan
Mehwish Hamid Department of Biochemistry, University of Karachi,Karachi,Pakistan
Uzma Salar HEJ Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi,Karachi,Pakistan
Yasmeen Rashid Department of Biochemistry, University of Karachi,Karachi,Pakistan
Khalid Mohammed Khan HEJ Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan;Department of Clinical Pharmacy, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia
M. Kamran Azim Department of Biosciences, Mohammad Ali Jinnah University,Karachi,Pakistan
Shahid Bashir Neuroscience Center, King Fahad Specialist Hospital,Dammam,Saudi Arabia
Abstract
The bacterial HslVU complex consists of two different proteins, i.e., the HslV protease and the HslU ATPase. The functional HslVU enzyme complex forms only when the HslU c-terminal helix is inserted into the cavity located between two adjacent HslV monomers in order to allosterically activate the HslV protease. Based on its essential role in maintaining microbial proteostasis as well its absence from human beings, it is considered a promising therapeutic target for designing antibacterial agents. The goal of the present study was to find out potential drug candidates that could overactivate the HslV protease and produce aberrant proteolysis in pathogenic bacteria. Derivatives of 3-substituted coumarin have been identified as potential HslV protease activators based on their highest docking scores, ideal interaction patterns, and significant in-vitro HslV activation potential. Their ED50 values were in the sub-micromolar range, i.e., 0.40.48µM. The conformational stability of the contacts between the HslV dimer and the active compounds was further confirmed by molecular dynamics studies. Correspondingly, the ADMET characteristics of these lead molecules considerably demonstrated their significant non-toxic drug-like abilities. This research not only identified small nonpeptidic HslV protease activators but also improved the understanding of the mode of action of 3-substituted coumarin derivatives as antibacterials.
Publication Details
Page(s) 1241-1250
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 35, Issue: S4, Year: 2022

Request the full text from PASTIC

Keywords
the HslVU complex, 3-substituted coumarin derivatives, Structural bioinformatics, molecular docking studies, Antimicrobial drugs
References
Aurangzeb S,Hamid M,Rashid Y,Hameed A,Khan KM .2018 .Three dimensional structural investigation of lead molecules against neisseria meningitis pathogenic factors; A step towards drug designing. PJBMB, 51(1-2) : 31-56.
Azim MK .2021 .Structure of prokaryotic HslVU protease-chaperone complex. PJBMB, 54(1-2) : 6-13.
Azim MK,Goehring W,Song HK,Ramachandran R,Bochtler M,Goettig P .2005 .Characterization of the HslU chaperone affinity for HslV protease. Protein Sci, 14(5) : 1357-1362.
Banerjee P,Eckert AO,Schrey AK,Preissner R .2018 .ProTox-II: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Res, 46(1) : 257-263.
Barboza NR.,Cardoso J,de Paula Lima CV,Soares MJ,Gradia DF,Hangai NS,Bahia MT,de Lana M,Krieger MA,de Sa RG MA .2012 .Expression profile and subcellular localization of HslV, the proteasome related protease from Trypanosomacruzi. Exp. Parasito, 130(2) : 171-177.
Bochtler M,Ditzel L,Groll M,Huber R M .1997 .Crystal structure of heat shock locus V (HslV) from Escherichia coli. Proc. Natl. Acad. Sci, 94(12) : 6070-6074.
Brotz-Oesterhelt H,Sass P H .2014 .Bacterial caseinolytic proteases as novel targets for antibacterial treatment. Int. J. Med, 304(1) : 23-30.
Csizmadia P .1999 .MarvinSketch and MarvinView: molecule applets for the World Wide Web. , : .
Daina A,Michielin O,Zoete V .2017 .SwissADME: a free web tool to evaluate pharmacokinetics, druglikeness and medicinal chemistry friendliness of small molecules. Sci. Rep, 7(1) : 1-13.
Dallakyan S .2010 .. , : .
Garg SS,Gupta J,Sharma S,Sahu D S .2020 .An insight into the therapeutic applications of coumarin compounds and their mechanisms of action. Eur. J. Pharm. Sci., 152 : 105424.
Gersch M,Famulla K,Dahmen M,Gobl C,Malik I,Richter K,Korotkov VS,Rubsamen-Schaeff P,Madl H,Brotz-Oesterhelt T,H T .2015 .AAA+ chaperones and acyldepsipeptides activate the ClpP protease via conformational control. Nat. Commun, 6(1) : 1-12.
Hamid M,Aurangzeb S,Rashid Y,Khan KM,Hameed A .2021 .Identification and structural investigation of potential novel drug candidates against lethal human pathogen. Pak. J. Pharm. Sci., 34(1) : 21-34.
Humphrey W,Dalke A,Schulten K A .1996 .VMD: visual molecular dynamics. J. Mol. Graph, 14(1) : 33-38.
Hunanyan L,Ghamaryan V,Makichyan A,Popugaeva E .2021 .Computer-based drug design of positive modulators of store-operated calcium channels to prevent synaptic dysfunction in Alzheimer's disease. Int. J. Mol. Sci, 22(24) : 13618.
Jeong S,Ahn J,Kwon AR,Ha NC .2020 .Cleavagedependent activation of ATP-dependent protease HslUV from Staphylococcus aureus. Mol. Cells, 43(8) : 694.
Kalkhambkar RG,Kulkarni GM,Kamanavalli CM,Premkumar N,Asdaq SMB,Sun CM .2008 .Synthesis and biological activities of some new fluorinated coumarins and 1-aza coumarins. Eur. J. Med, 43(10) : 2178-2188.
Kebe NM,Samanta K,Singh P,Lai-Kee-Him J,Apicella V,Payrot N,Lauraire N,Legrand B,Lisowski V,Mbang-Benet DE,Pages M .2019 .The HslV protease from Leishmania major and its activation by C-terminal HslU peptides. Int. J. Mol. Sci, 20(5) : 1021.
Lopez-Blanco JR,Aliaga JI,Chacon P .2014 .iMODS: internal coordinates normal mode analysis server. Nucleic Acids Res, 42(1) : 271-276.
Meng XY,Zhang HX,Mezei M,Cui M M .2011 .Molecular docking: A powerful approach for structurebased drug discovery. Curr. Comput. Aided Drug Des., 7(2) : 146-157.
Missiakas D,Schwager F,Betton JM,Georgopoulos C,Raina S C .1996 .Identification and characterization of HsIVHsIU (ClpQClpY) proteins involved in overall proteolysis of misfolded proteins in Escherichia coli. EMBO J, 15(24) : 6899-6909.
Moreno-Cinos C,Goossens K,Salado IG,Van Der Veken P,De Winter H and Augustyns K P .2019 .ClpP protease, a promising antimicrobial target. Int. J. Mol. Sci, 20(9) : 2232.
Pangal A,Gazge M,Mane V,Shaikh JA .2013 .Various pharmacological aspects of coumarin derivatives: A review. IJPRBS, 2(6) : 168-194.
Park E,Lee JW,Eom SH,Seol JH,Chung CH .2008 .Binding of MG132 or deletion of the Thr active sites in HslV subunits increases the affinity of HslV protease for HslU ATPase and makes this interaction nucleotideindependent. J. Biol. Chem, 283(48) : 33258-33266.
Ramachandran R,Hartmann C,Huber HK,Bochtler R,M R .2002 .Functional interactions of HslV (ClpQ) with the ATPase HslU (ClpY). Proc. Natl. Acad. Sci, 99(11) : 7396-7401.
Ramasamy G,Gupta D,Mohmmed A,Chauhan VS .2007 .Characterization and localization of Plasmodium falciparum homolog of prokaryotic ClpQ/HslV protease. Mol. Biochem, 152(2) : 139-148.
Rashid Y,Azim MK,Khan ZS,Khan KM,R KM .2012 .Small molecule activators of proteasomerelated HslV peptidase. Bioorg. Med, 22(19) : 6089-6094.
Salar U,Muhammad KM,Fakhri H,Perveen MI,Choudhary S,MI S .2018 .Anti-MRSA (Multidrug resistant Staphylococcus aureus) activity of 3- substituted coumarins. Lett. Drug Des, 15(4) : 353-362.
Seong IS,Kang MS,MK MS,Koh JW,Wang OJ,Eom J,Chung SH,CH SH .2002 .The C-terminal tails of HslU ATPase act as a molecular switch for activation of HslV peptidase. J. Biol. Chem, 277(29) : 25976-25982.
Singh P,Samanta K,Kebe NM,Michel G,Legrand B,Sitnikova VE,Kajava AV,Pages M,Bastien P,Pomares C,Coux O C .2022 .The C-terminal segment of Leishmania major HslU: Toward potential inhibitors of LmHslVU activity. Bioorg. Chem, 119 : 105539.
Singh G,Soni H,Tandon S,Kumar V,Babu G,Gupta V,Chaudhuri P .2022 .Identification of natural DHFR inhibitors in MRSA strains: Structure-based drug design study. Results Chem, 4 : 100292.
Sousa MC,Trame CB,Tsuruta H,Wilbanks SM,Reddy VS,McKay DB .2000 .Crystal and solution structures of an HslUV protease-chaperone complex. Cell, 103(4) : 633-643.
Olson Trott O,AJ Trott O .2010 .AutoDockVina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem, 31(2) : 455-461.
Tschan S,Kreidenweiss A,Stierhof YD,Sessler N,Fendel R,Mordmüller B .2010 .Mitochondrial localization of the threonine peptidase PfHslV, a ClpQortholog in Plasmodium falciparum. Int. J. Parasitol., 40(13) : 1517-1523.
Visualizer DS .2005 .Accelrys Software Inc. Discovery Studio Visualizer, 2 : .
Wernli D,Jørgensen PS,Harbarth S,Carroll SP,Laxminarayan R,Levrat N,Røttingen JA,Pittet D JA .2017 .Antimicrobial resistance: The complex challenge of measurement to inform policy and the public. PLoS Med, 14(8) : 1002378.
Wu L,Wang X,Xu W,Farzaneh F,Xu R F .2009 .The structure and pharmacological functions of coumarins and their derivatives Curr. Med, 16(32) : 4236-4260.
Yoo SJ,Seol JH,Shin DH,Rohrwild M,Kang MS,Tanaka K,Goldberg AL,Chung CH .1996 .Purification and characterization of the heat shock proteins HslV and HslU that form a new ATPdependent protease in Escherichia coli. J. Biol. Chem, 271(24) : 14035-14040.
0

Citations

0

Downloads

11

Views